Market Cap

Enlivex Therapeutics Ltd. Market Capitalization:

₪104.9 Million

ILS as of July 1, 2024

US$27.9 Million

business Enlivex Therapeutics Ltd. Company Profile

Enlivex Therapeutics Ltd. Main Stock Listing

TASE: ENLV

Market Capitalization History of Enlivex Therapeutics Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Enlivex Therapeutics Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 ₪232.4 M -11.34%
Jan. 1, 2023 ₪262.2 M -12.32%
Jan. 1, 2022 ₪299.0 M -58.22%
Jan. 1, 2021 ₪715.7 M 33.48%
Jan. 1, 2020 ₪536.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Enlivex Therapeutics Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

Enlivex Therapeutics Ltd. has the following listings and related stock indices.


Stock: TASE: ENLV

Stock: NASDAQ: ENLV

Stock: FSX: 1BT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.